DIGIANDOMENICO ANTHONY 4
4 · ENDRA Life Sciences Inc. · Filed Oct 15, 2025
Insider Transaction Report
Form 4
DIGIANDOMENICO ANTHONY
Director
Transactions
- Award
Common Stock
2025-10-10$7.06/sh+70,822$500,003→ 76,265 total - Award
Warrants
2025-10-10$7.06/sh+141,644$1,000,007→ 141,644 totalExercise: $6.81From: 2025-10-15Exp: 2030-10-15→ Common Stock (141,644 underlying)
Footnotes (3)
- [F1]The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended.
- [F2]Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock.
- [F3]Includes unvested restricted stock units.